Additionally, NAMPT-specific inhibitors lower NAD+ levels and the activity of metabolic pathways including glycolysis, the citric acid cycle, and OXPHOS, thereby helping to suppress cancer cell proliferation [172]. The gene discussed is NAMPT; the disease is cancer.